Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Dynavax Technologies Q3 EPS $0.21 Beats $0.12 Estimate, Sales $94.876M Beat $94.003M Estimate

Author: Benzinga Newsdesk | November 05, 2025 04:02pm
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.12 by 75 percent. This is a 75 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $94.876 million which beat the analyst consensus estimate of $94.003 million by 0.93 percent. This is a 17.67 percent increase over sales of $80.630 million the same period last year.

Posted In: DVAX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist